Explore how E-selectin-targeted polymer-doxorubicin therapy induces regression in colorectal liver metastases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback